findmyKOL
Clinical trialNCT05033990RecruitingObservational

SPIROMICS Study of Early COPD Progression (SOURCE)

SponsorUniversity of Massachusetts, WorcesterEnrollment1,000COPD, Early-Onset
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: * To use CT scan imaging to identify which smokers will develop COPD. * To identify biomarkers predictive of smokers that will develop COPD. * To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD. Procedures (methods): All participants will undergo study related questionnaires assessing medical history, smoke exposure and use, medication use, social and behavioral health, pulmonary symptoms, food frequency, and will provide nasal swab, blood, stool, and urine samples, pulmonary function testing to determine function, sputum induction to provide a sputum sample for airway biospecimen analysis, and CT imaging of the lungs.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

    J. Michael Wells, MD
    Recruiting
  • Mayo Clinic Arizona

    Scottsdale, Arizona, United States

    Victor Ortega, MD
    Recruiting
  • University of California Los Angeles

    Los Angeles, California, United States

    Igor Barjaktarevic, MD, PhD
    Recruiting
  • University of California, San Francisco

    San Francisco, California, United States

    Prescott G. Woodruff, MD, MPH
    Recruiting
  • National Jewish Health

    Denver, Colorado, United States

    Claudia Onofrei, MD
    Recruiting
  • University of Illinois Chicago

    Chicago, Illinois, United States

    Jerry Krishnan, MD, PhD
    Recruiting
  • University of Iowa

    Iowa City, Iowa, United States

    Alejandro Comellas, MD
    Recruiting
  • Johns Hopkins Bayview Medical Center

    Baltimore, Maryland, United States

    Nadia Hansel, MD, MPH
    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Meilan Han, MD, MPH
    Recruiting
  • Columbia University

    New York, New York, United States

    R. Graham Barr, MD, PhD
    Recruiting
  • Weill Cornell Medical Center

    New York, New York, United States

    Robert Kaner, MD
    Recruiting
  • Wake Forest

    Winston-Salem, North Carolina, United States

    Jessica Bon, MD
    Recruiting
  • Temple University

    Philadelphia, Pennsylvania, United States

    Nathaniel Marchetti, DO
    Recruiting
  • University of Utah

    Salt Lake City, Utah, United States

    Robert Paine, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 Sept 2021
Primary completion
31 May 2027
Completion
31 May 2027
Last update posted
3 Jun 2026
Registered enrollment
1,000
Registry id
NCT05033990

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.